

This week, you can download, The Metaverse - What is it? And How to Profit with These 5 Pioneering Stocks. And in a new FREE report, Zacks is revealing those stocks to you. What do they know that you don't? They’re aware of the companies best poised to grow as the metaverse does. The inevitable result? Many investors will get rich as the metaverse evolves. Facebook even rebranded itself as Meta because Mark Zuckerberg believes the metaverse is the next iteration of the internet. The metaverse is gaining steam every day. Just Released: Free Report Reveals Little-Known Strategies to Help Profit from the $30 Trillion Metaverse Boom In addition to impressive profit potential, these trades can actually reduce your risk. Looking to Trade Options?Ĭheck out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. This is a strategy many seasoned traders use because it captures decay. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. Given the way analysts feel about Quest Diagnostics right now, this huge implied volatility could mean there’s a trade developing. The net effect has taken our Zacks Consensus Estimate for the current quarter from $2.25 per share to $2.26 in that period. Over the last 60 days, two analysts have increased the earnings estimates for the current quarter, while four have revised the estimates downward.

Clearly, options traders are pricing in a big move for Quest Diagnostics shares, but what is the fundamental picture for the company? Currently, Quest Diagnostics is a Zacks Rank #3 (Hold) in the Medical - Outpatient and Home Healthcare industry that ranks in the Bottom 23% of our Zacks Industry Rank.
